POTSDAM, Germany, May 4, 2021 /CNW/ – Iuvo Therapeutics Ltd. (“Iuvo”) is pleased to announce the importation of 20,000 units of full-spectrum extracts derived from non-irradiated GMP certified cannabis flower from partner Cann Group Limited (“Cann Group”). This import is a key milestone for Iuvo to become one of Europe’s largest suppliers of cannabinoid-based pharmaceuticals.

Iuvo will be offering two full-spectrum extracts, a high THC and a balanced THC:CBD, both manufactured from premium non-irradiated GMP certified cannabis flower.

Germany continues to be Europe’s largest medicinal cannabis market, the demand for cannabinoid extracts has been growing steadily over the last few years increasing from approximately 80,000 prescriptions in 2019 to approximately 200,000 in 2020.

Iuvo Therapeutics Ltd. CEO Jonathan…



Read Full Article Here